Can olanzapine (atypical antipsychotic) cause seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Olanzapine Cause Seizures?

Yes, olanzapine can cause seizures, although the risk is relatively low (approximately 0.9% of patients) when used at therapeutic doses. 1 The medication should be used cautiously in patients with a history of seizures or conditions that lower the seizure threshold.

Seizure Risk with Olanzapine

Olanzapine has been documented to lower the seizure threshold in a dose-dependent manner. According to the FDA drug label:

  • Seizures occurred in 0.9% (22/2500) of olanzapine-treated patients during premarketing testing 1
  • The risk may be higher in certain populations, particularly:
    • Elderly patients (65 years or older)
    • Patients with a history of seizures
    • Patients with conditions that lower seizure threshold (e.g., Alzheimer's dementia)

Case Reports of Olanzapine-Induced Seizures

Several case reports have documented seizures associated with olanzapine use:

  • Myoclonic status in a 54-year-old woman with probable Alzheimer's disease shortly after adding olanzapine 2
  • Repetitive focal motor seizures with lingual dystonia in a psychiatric patient 3
  • Generalized tonic-clonic seizures in a 71-year-old man within 24 hours of starting olanzapine at a subtherapeutic dose (1.25 mg twice daily) 4
  • Status epilepticus in a 48-year-old woman after switching from quetiapine to olanzapine 5
  • New-onset generalized tonic-clonic seizure in a 23-year-old female with mild mental retardation and schizophrenia 6

Risk Factors for Olanzapine-Induced Seizures

Several factors may increase the risk of seizures with olanzapine:

  • Advanced age
  • History of stroke or seizures
  • Cognitive impairment/dementia
  • Concomitant use of other medications that lower seizure threshold
  • Higher doses of olanzapine
  • Polypharmacy, particularly when combined with other psychotropic medications

Clinical Recommendations

When prescribing olanzapine, consider the following:

  1. Screen for seizure risk factors before initiating treatment
  2. Start with lower doses in patients with risk factors for seizures
  3. Monitor closely for any signs of seizure activity, especially during dose adjustments
  4. Use caution when combining with other medications that may lower seizure threshold
  5. Consider alternative antipsychotics in patients with a history of seizures or significant risk factors

Comparison to Other Atypical Antipsychotics

Clozapine has a higher seizure risk (approximately 5% at high doses) compared to olanzapine 7. The American Academy of Child and Adolescent Psychiatry notes that during a study of clozapine in youth with childhood-onset schizophrenia, two patients developed seizures, highlighting this risk 7.

Special Considerations

In patients with epilepsy or a history of seizures who require antipsychotic medication, careful monitoring and possibly prophylactic anticonvulsant therapy may be warranted when using olanzapine.

If a patient develops a seizure while on olanzapine, immediate discontinuation of the medication should be considered, especially if no other clear etiology for the seizure is identified.

References

Research

Olanzapine-induced myoclonic status.

Clinical neuropharmacology, 2005

Research

Olanzapine-related repetitive focal seizures with lingual dystonia.

Epileptic disorders : international epilepsy journal with videotape, 2016

Research

Status epilepticus in a patient treated with olanzapine and mirtazapine.

International journal of clinical pharmacology and therapeutics, 2009

Research

Seizure associated with olanzapine.

Journal of family medicine and primary care, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.